Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real‐world claims data analysis

BACKGROUND: Adherence and persistence rates of anticholinergic (ACH) therapies have been well described. To date, few studies describe these metrics for mirabegron in patients with overactive bladder. METHODS: This retrospective analysis of MarketScan(®) database assessed adherence and persistence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sussman, D., Yehoshua, A., Kowalski, J., Lee, W., Kish, J., Chaudhari, S., Murray, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680256/
https://www.ncbi.nlm.nih.gov/pubmed/28371019
http://dx.doi.org/10.1111/ijcp.12824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680256/
https://www.ncbi.nlm.nih.gov/pubmed/28371019
http://dx.doi.org/10.1111/ijcp.12824

Ejemplares similares